v3.25.1
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)
3 Months Ended
Mar. 31, 2025
CAD ($)
$ / shares
shares
Mar. 31, 2024
CAD ($)
$ / shares
shares
Profit or loss [abstract]    
Sales of goods $ 1,541,811 $ 1,237,948
Provision of services 5,904 91,633
TOTAL REVENUE 1,547,715 1,329,581
COST OF SALES (1,237,627) (1,049,570)
GROSS PROFIT 310,088 280,011
OPERATING EXPENSES    
Amortization 2,257 2,821
Depreciation 75,416 143,122
Director fees 132,651 152,438
Insurance 155,749 364,274
Office and miscellaneous 537,689 346,270
Professional fees 790,177 580,260
Research and development 161,886 121,391
Share-based payments 288,883 198,907
Travel 125,008 40,019
Wages and salaries 1,641,319 1,581,431
Total operating expenses (3,911,035) (3,530,933)
OTHER INCOME    
Change in fair value of derivative liability 157,830 1,817,569
Finance and other costs 34,031 4,825
Foreign exchange gain (loss) (17,240) 66,736
Gain on disposal of assets 43,528
Gain on recovery of notes receivable 25,951 6,751
Other expense (24,450) (552,295)
 Total Other operating income 176,122 1,387,114
NET LOSS (3,424,825) (1,863,808)
Items that may be reclassified to profit or loss    
Foreign exchange translation (16,060) (9,562)
Items that will not be reclassified to profit or loss    
Change in fair value of equity investments at FVOCI 7,173 (11,046)
COMPREHENSIVE LOSS $ (3,433,712) $ (1,884,416)
Net Loss per share - Basic | $ / shares $ (0.63) $ (0.85)
Net Loss per share - Diluted | $ / shares $ (0.63) $ (0.85)
Weighted average number of common shares outstanding - Basic | shares 5,427,795 2,197,354
Weighted average number of common shares outstanding - Diluted | shares 5,427,795 2,197,354